3D printing company UltiMaker signed a Memorandum of Understanding (MOU) with Bioactivx, a Singapore-based MedTech startup, to co-develop a scalable, on-demand medical printing solution for regenerative wound care.
The announcement coincides with two major milestones for Bioactivx: the opening of its medical-grade filament production and cleanroom print farm facility, and its obtainment of HSA approval for their flagship product Bioactiv® Matrix, manufactured using UltiMaker’s 3D printing platform.
Singapore’s HSA is classified as WHO maturity level 4 for medical device regulations, indicating extremely high standards for medical device approvals. Regulatory submissions for the Bioactiv® Matrix in key countries/regions such as USA, EU, Australia and the rest of ASEAN are ongoing.
Bioactiv® Matrix
Bioactivx’s flagship product, Bioactiv® Matrix, is a synthetic, animal-free regenerative medical solution designed to accelerate wound closure and promote scar-free healing.
To bring it to market at scale, Bioactivx built an end-to-end digital manufacturing process, compounding a proprietary active-ingredient filament in-house, then mass-producing the final product on a fleet of UltiMaker 3D printers within a certified cleanroom.
“We chose UltiMaker because of its reliability, ease of use, and open architecture,” said Dr. Teo Peili, CEO of Bioactivx. “That openness was essential – it let us develop and fine-tune our own proprietary print process rather than working around the limitations of a closed system.”
Under the newly signed MOU, UltiMaker and Bioactivx will jointly develop a scalable, deployable printing solution aimed at bringing wound care production closer to the point of need.
The two companies aim to enable faster access to treatment within the critical “golden period” following injury, by reducing dependency on traditional cold-chain logistics and centralized manufacturing.
*We curate insights that matter to help you grow in your AM journey. Receive them once a week, straight to your inbox. Subscribe to our weekly newsletter.
